Trials / Withdrawn
WithdrawnNCT02020109
Evaluation of Splenic Irradiation in Chronic Lymphatic Leukemia
Evaluation of Splenic Irradiation in Chronic Lymphatic Leukemia (CLL)
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Maastricht Radiation Oncology · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Retrospective evaluation on the effect of splenic irradiation on clinical and hematological response and toxicity in patients with chronic lymphatic leukaemia (CLL).
Detailed description
The study will include patients with CLL treated with splenic irradiation in Maastro Clinic, Maastricht, The Netherlands, Maxima Medisch Centrum Veldhoven/Catharina hospital, Eindhoven, The Netherlands and Modena hospital, Modena, Italy. Data will be collected from patient records in an uniform database. Data will include demographic data, CLL stadium (RAI and Binet) at diagnosis and at the time of irradiation treatment, clinical data at diagnosis (haematology), splenic irradiation data, follow-up data such as date of progression or death
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | splenic irradiation |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2016-12-01
- Completion
- 2017-01-01
- First posted
- 2013-12-24
- Last updated
- 2018-04-05
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT02020109. Inclusion in this directory is not an endorsement.